Activating mutations in CSF-1R and additional receptor tyrosine kinases in histiocytic neoplasms
Sign Up to like & getrecommendations! Published in 2019 at "Nature medicine"
DOI: 10.1038/s41591-019-0653-6
Abstract: Histiocytoses are clonal hematopoietic disorders frequently driven by mutations mapping to the BRAF and MEK1 and MEK2 kinases. Currently, however, the developmental origins of histiocytoses in patients are not well understood, and clinically meaningful therapeutic… read more here.
Keywords: additional receptor; mutations csf; receptor tyrosine; activating mutations ... See more keywords